In contrast, des-gamma-carboxy prothrombin (DCP) demonstrates superior performance with 48–89% sensitivity and 81–98% specificity for HCC diagnosis, exceptional utility in AFP-negative cases, and dynamically changing levels that reflect tumor biology, positioning it as a potential early response indicator (11–13). The gene discussed is AFP; the disease is hepatocellular carcinoma.